Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nrc Health (NRC) Non-Current Assets (2016 - 2026)

Nrc Health's Non-Current Assets history spans 16 years, with the latest figure at $114.7 million for Q4 2025.

  • On a quarterly basis, Non-Current Assets rose 5.53% to $114.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $460.8 million, a 324.08% increase, with the full-year FY2025 number at $114.7 million, up 5.53% from a year prior.
  • Non-Current Assets hit $114.7 million in Q4 2025 for Nrc Health, down from $115.3 million in the prior quarter.
  • Over the last five years, Non-Current Assets for NRC hit a ceiling of $116.1 million in Q2 2025 and a floor of $81.0 million in Q4 2022.
  • Historically, Non-Current Assets has averaged $96.3 million across 5 years, with a median of $93.0 million in 2023.
  • Biggest five-year swings in Non-Current Assets: decreased 3.34% in 2022 and later grew 16.46% in 2024.
  • Tracing NRC's Non-Current Assets over 5 years: stood at $83.8 million in 2021, then fell by 3.34% to $81.0 million in 2022, then grew by 15.21% to $93.4 million in 2023, then rose by 16.4% to $108.7 million in 2024, then rose by 5.53% to $114.7 million in 2025.
  • Business Quant data shows Non-Current Assets for NRC at $114.7 million in Q4 2025, $115.3 million in Q3 2025, and $116.1 million in Q2 2025.